Date Filed | Type | Description |
05/08/2023 |
4
| Kwan Rudolf (EVP, Chief Medical Officer) has filed a Form 4 on Athenex, Inc.
Txns:
| Granted 3,603 shares
@ $1.36, valued at
$4.9k
|
|
04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/27/2023 |
4
| Kwan Rudolf (EVP, Chief Medical Officer) has filed a Form 4 on Athenex, Inc.
Txns:
| Granted 3,525 shares
@ $1.39, valued at
$4.9k
|
|
03/13/2023 |
4
| Kwan Rudolf (EVP, Chief Medical Officer) has filed a Form 4 on Athenex, Inc.
Txns:
| Granted 2,526 shares
@ $1.94, valued at
$4.9k
|
|
02/27/2023 |
4
| Kwan Rudolf (EVP, Chief Medical Officer) has filed a Form 4 on Athenex, Inc.
Txns:
| Granted 1,788 shares
@ $2.74, valued at
$4.9k
|
|
02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/31/2023 |
4
| Kwan Rudolf (EVP, Chief Medical Officer) has filed a Form 4 on Athenex, Inc.
Txns:
| Granted 25,323 shares
@ $0.1935, valued at
$4.9k
|
|
01/17/2023 |
4
| Kwan Rudolf (EVP, Chief Medical Officer) has filed a Form 4 on Athenex, Inc.
Txns:
| Granted 26,344 shares
@ $0.186, valued at
$4.9k
|
|
01/03/2023 |
4
| Kwan Rudolf (EVP, Chief Medical Officer) has filed a Form 4 on Athenex, Inc.
Txns:
| Granted 33,220 shares
@ $0.1475, valued at
$4.9k
|
|
12/20/2022 |
4
| Kwan Rudolf (EVP, Chief Medical Officer) has filed a Form 4 on Athenex, Inc.
Txns:
| Granted 41,386 shares
@ $0.1184, valued at
$4.9k
|
|
12/06/2022 |
4
| Kwan Rudolf (EVP, Chief Medical Officer) has filed a Form 4 on Athenex, Inc.
Txns:
| Granted 24,623 shares
@ $0.199, valued at
$4.9k
|
|
11/21/2022 |
4
| Kwan Rudolf (EVP, Chief Medical Officer) has filed a Form 4 on Athenex, Inc.
Txns:
| Granted 25,257 shares
@ $0.194, valued at
$4.9k
|
|
11/08/2022 |
4
| Kwan Rudolf (EVP, Chief Medical Officer) has filed a Form 4 on Athenex, Inc.
Txns:
| Granted 25,103 shares
@ $0.1952, valued at
$4.9k
|
|
10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/12/2022 |
4
| Kwan Rudolf (EVP, Chief Medical Officer) has filed a Form 4 on Athenex, Inc.
Txns:
| Granted 20,340 shares
@ $0.2409, valued at
$4.9k
|
|
09/27/2022 |
4
| Kwan Rudolf (EVP, Chief Medical Officer) has filed a Form 4 on Athenex, Inc.
Txns:
| Granted 20,333 shares
@ $0.241, valued at
$4.9k
|
|
09/12/2022 |
4
| Kwan Rudolf (EVP, Chief Medical Officer) has filed a Form 4 on Athenex, Inc.
Txns:
| Granted 10,572 shares
@ $0.4635, valued at
$4.9k
|
|
08/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/11/2022 |
4
| Kwan Rudolf (EVP, Chief Medical Officer) has filed a Form 4 on Athenex, Inc.
Txns:
| Granted 6,516 shares
@ $0.752, valued at
$4.9k
|
|
03/29/2022 |
4
| Kwan Rudolf (EVP, Chief Medical Officer) has filed a Form 4 on Athenex, Inc.
Txns:
| Granted 5,422 shares
@ $0.9038, valued at
$4.9k
|
|
11/17/2021 |
4
| Kwan Rudolf (EVP, Chief Medical Officer) has filed a Form 4 on Athenex, Inc.
Txns:
| Bought 4,000 shares
@ $2.05, valued at
$8.2k
|
|
08/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|